Editorial team
ioQuanta Research Desk
-
Evidence date ·How does one lipid particle link a T cell to a tumor cell?
Peer-Reviewed PaperTracked over timeA lipid particle with CD3- and HER2-binding fragments helped T cells kill HER2-positive tumor cells in models; a third binder targets PD-L1.
-
Evidence date ·One T-cell bridge can carry three ways to recognize myeloma
Peer-Reviewed PaperTracked over timeCompared with single-target versions, three-target particles increased myeloma-cell killing in marrow-like cultures and delayed tumor progression in mice.
-
Evidence date ·How do immune cells reach a tumor inside a chip?
Review or Meta-AnalysisA 2021 review explains why a vessel-like barrier matters for tumor chips and how image analysis can track immune-cell behavior as conditions change.
-
Evidence date ·Lightweight rocket tanks face a materials puzzle in deep cold and liquid oxygen
Review or Meta-AnalysisA 2021 review finds polymer strength and stiffness can rise in deep cold even as impact resistance falls, while liquid oxygen adds a chemical hazard.
-
Evidence date ·Why did a metal-binding composite slow algal growth?
Review or Meta-AnalysisA 2021 review explains how cellulose–polyethyleneimine composites bind metals, and how polymer release affected algae in one reported formulation.
-
Evidence date ·Could a persistent rash during immunotherapy matter before blisters?
Review or Meta-AnalysisA review of 58 cases found that an itchy eruption sometimes preceded blisters, and the skin disease often interrupted cancer immunotherapy.
-
Evidence date ·A lung biopsy can show which immune cells sit beside a tumor
Review or Meta-AnalysisA 2021 review shows how multiple stains reveal which cells carry PD-L1 and where immune cells sit in lung tumors. Earlier studies linked both patterns to survival.
-
Evidence date ·What recovered carbon fibers can become in new parts
Review or Meta-AnalysisA 2021 review estimated 24,000 tonnes of carbon-fiber waste but less than 1,000 tonnes recycled, citing uncertain material quality and buyer demand.
-
Evidence date ·Why a blood-cancer treatment faces different conditions inside solid tumors
Review or Meta-AnalysisCAR T cells can treat some B cell cancers. The review shows why solid tumors pose different hurdles: selecting a safe target, entering the tumor, and staying active inside it.
-
Evidence date ·Why did antibodies against an immune-cell brake fare differently in mice and people?
Review or Meta-AnalysisTracked over timeIn mice, anti-TIGIT antibodies that recruited other immune cells often controlled tumors better. In people, treatment alone disappointed and combinations gave mixed results.